Pacira Pharma Stock Price (NASDAQ:PCRX)

Add to My Stocks
$46.8 $0.15 (0.32%) PCRX stock closing price Aug 14, 2018 (Closing)
Prev Close* : $46.95
Market Cap:
Day Low: $46.75
52 Week Low: $26.95
Open: $46.8
Volume: -
Day High: $47.66
52 Week High: $47.66

Latest Stock Market News

Latest Articles

Pacira Pharma News - From Partners

PCRX Stockcharts

View PCRX PE ratio, PS ratio stocks charts and compare with peers.
PCRX Chart
Note: Compare Pacira Pharma stock price history with the index and industry peers.

Pacira Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Pacira Pharma Returns

(return on equity)

Pacira Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

PCRX Industry Peers

Company Price Change (%)
Ignyta (RXDX)26.950 (0%)
Ptc Therapeutics (PTCT)44.891.75 (4.06%)
Cara Therapeutics (CARA)18.420.25 (1.34%)
Acelrx Pharma (ACRX)3.050 (0%)
Durect (DRRX)1.310.01 (0.76%)
Heron Therapeutics (HRTX)39.60.85 (2.19%)
Avanos Medical (AVNS)63.250.68 (1.09%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)5.210.34 (6.98%)
TherapeuticsMD (TXMD)5.490.33 (6.4%)
ArQule (ARQL)6.020.34 (5.99%)
Endo International (ENDP)16.10.91 (5.99%)
MADRIGAL PHARMA (MDGL)236.8810.47 (4.62%)
Infinity Pharma (INFI)2.070.09 (4.55%)
PTC Therapeutics (PTCT)44.891.75 (4.06%)
Top gainers from Medical-Drugs industry
* As of Aug 15, 2018
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.291.38 (10.89%)
BioSpecifics Technologies (BSTC)49.963.65 (6.81%)
Galmed Pharma (GLMD)11.160.65 (5.5%)
Portola Pharma (PTLA)26.221.47 (5.31%)
Flexion Therapeutics (FLXN)22.831.13 (4.72%)
ACER THERAPEUTS (ACER)27.771.23 (4.24%)
MELINTA THERAPT (MLNT)4.70.2 (4.08%)
Top losers from Medical-Drugs industry
* As of Aug 15, 2018

Pacira Pharmaceuticals Inc Stock News - Partner Headlines

Pacira Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues286.63M276.37M248.99M197.66M85.55M
Net Income-42.61M-37.94M1.85M-13.71M-63.9M
Total Operating Expense223.65M198.28M167.7M125.39M84.06M
View Pacira Pharma income statement
balance sheet20172016201520142013
Total Assets628.37M391.46M389.62M326.07M169.82M
Total Liabilities348.88M172.49M171.23M154.92M128.57M
Shareholders Equity279.48M218.97M218.39M171.14M41.24M
View Pacira Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.57M22.27M-22.34M-0.45M-4.41M
Net Cash from (used by) Operating Activities17.78M33.45M28.99M25.46M-43.21M
Increase (Decrease) in Prop Plant And Equipment-19.26M-24.7M-41.27M-21.88M-12.79M
View Pacira Pharma cash flow statement

Pacira Pharma Stock Message Board

Pacira Pharma stock lost 0.32%, and the last close price as of Aug 14, 2018 is $46.8 for PCRX stock. Looking at Pacira Pharma market capitalization, which currently stands at $1.92B, we can say that PCRX stock is a Small Cap stock. Pacira Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy PCRX stock than sell it, then Pacira Pharma stock price goes up. Conversely, if more investors wanted to sell PCRX stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Pacira Pharma stock quote data shows the number of shares traded. For Ex: 369,880 Pacira Pharma shares were traded as of last trading day, as seen from Pacira Pharma stock chart. Pacira Pharma paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Pacira Pharma stock price history.